Some of our partners
10 times Diverse & High-Performance Biopharmaceutical Drug Discovery
Maximizing results from the laboratory with AI
Our patented technology
MOLCURE uses NGS to generate big data from the samples collected from evolutionary molecular engineering experiments and uses AI technology to refine the selection of high-quality biopharmaceutical candidates.
Example of service implementation
We will be pleased to make a proposal that meets your needs. Please feel free to contact us.
How to order
Team
Ryu Ogawa, Ph.D.
CEO/Co-founder
Satoshi Tamaki, Ph.D.
CSO
Yutaro Kyono
CTO/Co-founder
Kengo Miura
External director
Tatsuo Tsutsumi
External director
Hiroshi Abe
Statutory auditor
Koichi Takahashi, Ph.D.
Adviser
Get in touch
Email: contact@molcure.io